[ad_1] Newswise — TAMPA (Sunday, March 26, 2023) – After resolving missing data burdens, the ENGOT-OV16/NOVA (NCT01847274) study data shows no difference in overall survival for...
[ad_1] Newswise — TAMPA (Saturday, March 25, 2023) – Administering PARP inhibitor (PARPi) olaparib prior to surgical intervention and chemotherapy in ovarian cancer patients with a...